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Research Article
Oral Exposure to Commercially Available Coal
Tar-Based Pavement Sealcoat InducesMurine Genetic
Damage andMutations
Alexandra S. Long,1,2* Margaret Watson,2 Volker M. Arlt,3 and
Paul A.White1,2
1Department of Biology, University of Ottawa, Ottawa, Ontario, Canada
2Mechanistic Studies Division, Environmental Health Science and Research
Bureau, Environmental and Radiation Health Sciences Directorate, HECSB,
Health Canada, Ottawa, Ontario, Canada
3Analytical and Environmental Sciences Division, MRC-PHE Centre for Environ-
ment and Health, King’s College London, London, United Kingdom
Coal tar (CT) is a thick black liquid produced as
a by-product of coal carbonization to produce
coke or manufactured gas. It is comprised a
complex mixture of polycyclic aromatic com-
pounds, including a wide range of polycyclic
aromatic hydrocarbons (PAHs), many of which
are genotoxic and carcinogenic. CT is used in
some pavement sealants (also known as seal-
coat), which are applied to pavement in order
to seal and beautify the surface. Human expo-
sure is known to occur not only during applica-
tion, but also as a result of the weathering
process, as elevated levels of PAHs have been
found in settled house dust in residences adja-
cent to CT-sealed surfaces. In this study we
examined the genotoxicity of an extract of a
commercially available CT-based sealcoat in the
transgenic MutaTMMouse model. Mice were oral-
ly exposed to 3 doses of sealcoat extract daily
for 28 days. We evaluated genotoxicity by
examining: (1) stable DNA adducts and (2) lacZ
mutations in bone marrow, liver, lung, small
intestine, and glandular stomach, as well as (3)
micronucleated red blood cells. Significant
increases were seen for each endpoint and in
all tissues. The potency of the response differed
across tissues, with the highest frequency of
adducts occurring in liver and lung, and the
highest frequency of mutations occurring in small
intestine. The results of this study are the first
demonstration of mammalian genotoxicity follow-
ing exposure to CT-containing pavement seal-
coat. This work provides in vivo evidence to
support the contention that there may be adverse
health effects in mammals, and potentially in
humans, from exposure to coal tar. Environ.
Mol. Mutagen. 57:535–545, 2016. VC 2016 Her
Majesty the Queen in Right of Canada
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INTRODUCTION
Driveway sealants (i.e., sealcoats) are widely used
across North America by homeowners and commercial
property owners to beautify and protect asphalt and con-
crete surfaces. There are two main formulations of seal-
coat products used in North America: aqueous emulsions
containing 10-35% coal tar (CT) and aqueous emulsions
containing a similar level of asphalt (i.e., bitumen) [Mah-
ler et al., 2005]. Crude CT used in the production of the
former is a thick black liquid, generated as a by-product
of coal carbonization to produce coke or manufactured
gas. CT-based sealcoats generally contain a refined mate-
rial known as RT-12 (i.e., ASTM D490, Road Tar 12),
which is derived from high-temperature CT pitch, the
material that remains after removal of distillation products
such as light and medium oils from crude CT. RT-12 is
the most viscous of 12 refined products derived from
high-temperature CT pitch.
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CT is well recognized as a multi-organ carcinogen in
experimental animals [Robinson et al., 1987; Culp et al.,
1998; Goldstein et al., 1998], and CT and CT pitch are both
known human carcinogens [IARC, 1985; IARC, 2010a,b].
They contain a complex mixture of polycyclic aromatic
compounds (PACs), including a wide range of polycyclic
aromatic hydrocarbons (PAHs), many of which have the
ability to damage DNA (i.e., are genotoxic), as well as
cause mutations and cancer [IARC, 1983, 2010b]. In con-
trast, asphalt (‘bitumen’ in Europe), which is similar in
appearance to CT, is a by-product of petroleum refining and
contains only low concentrations of genotoxic and carcino-
genic PAHs. In addition, according to IARC’s 2011 evalua-
tion, there is only limited evidence that bitumens are animal
carcinogens [IARC, 2011]. The concentration of priority
PAHs (i.e., the 16 PAHs designated by the US EPA as pri-
orities for concern and control [Keith and Telliard, 1979])
in CT-based sealcoats is more than 1000-fold greater than
in asphalt-based products [Mahler et al., 2012]. Although
usage data for CT-based sealcoats in Canada are not avail-
able, it is estimated that 320 million litres of CT-based seal-
coat are used annually in the United States (US) [Scoggins
et al., 2009]. An estimated 82 to 100 kilotonnes of CT pitch
is produced annually in Canada (unpublished data).
Sealcoat is applied to surfaces by either rolling/spread-
ing or spraying. Human exposure is known to occur dur-
ing the application process as well as from volatilization
while drying. Subsequent exposure to particulate material
can also occur from surface weathering. Two hours fol-
lowing product application, volatile PAH concentrations
in air sampled at 0.03 m above CT-sealed lots are 5000-
fold greater than those above unsealed lots [Van Metre
et al., 2012]. In addition, PAH concentrations in water
runoff from CT-sealed lots were shown to be 65-fold
higher than in runoff from asphalt-sealed lots, and a study
of 40 US lakes determined that CT sealcoat was likely
the greatest contributor to elevated levels of sediment
PAHs [Mahler et al., 2005; Van Metre and Mahler,
2010]. Finally, PAH levels in settled house dust (i.e.,
SHD) collected from apartments adjacent to CT-sealed
lots were found to be 25-fold higher than SHD samples
from apartments adjacent to asphalt-sealed lots, a differ-
ence that has been translated into significant elevations in
excess lifetime cancer risk [Mahler et al., 2010; Williams
et al., 2013]. A ban on CT-based pavement sealcoats was
implemented in the city of Austin, TX in November,
2005, and subsequent analysis of priority PAH levels in
dated lake sediment cores showed a 44% decline in mean
levels from 1998–2005 to 2006–2012 [Van Metre and
Mahler, 2014]. Recently, in an effort to reduce PAH load-
ing to local waterways via storm water discharge, other
municipalities (e.g., Washington, DC) have implemented
similar bans [District of Columbia, 2013].
The toxicity of CT-based sealcoats and runoff has been
demonstrated in several aquatic organisms. Studies of
Ceriodaphnia dubia, Pimephales promelas [Mahler et al.,
2015] and Xenopus laevis [Bryer et al., 2006] exposed to
CT-sealcoat runoff, and freshwater macroinvertebrates
[Bryer et al., 2010] exposed to CT-sealcoat in soil
showed increased mortality relative to controls. Eastern
newts exposed to CT-sealcoat in sediment also demon-
strated signs of toxicity [Bryer et al., 2010]. Additionally,
a study by Kienzler et al. [2015] that employed the comet
assay, showed increased DNA damage in a piscine liver
cell line exposed to diluted CT sealcoat runoff.
Collectively, the aforementioned studies and reviews
indicate that crude CT is mutagenic and carcinogenic,
and known to contain a wide range of mutagenic and car-
cinogenic PAHs. Moreover, emissions from pavements
treated with CT-based sealcoat products, which can con-
tribute to elevated levels of PAHs in air, SHD, soil, and
aquatic sediments, are toxic and/or genotoxic to a variety
of organisms. As such, CT-based sealcoats constitute an
environmental and human health hazard. However,
although the genetic toxicity and carcinogenicity of CT
and PAHs have been well documented [IARC, 1983;
Culp et al., 1998; IARC, 2010b], the mammalian geno-
toxicity of commercially available CT-based sealcoats has
hitherto not been investigated.
In the current study, we have used the MutaTMMouse
system to examine the genetic toxicity of an extract of a
commercially available CT-based sealcoat. We have previ-
ously demonstrated the ability to integrate several genotox-
icity endpoints into a single in vivo murine study by
employing the transgenic MutaTMMouse system [Lemieux
et al., 2011]. Additionally, we have shown the reliability of
the study design to detect induced mutations in multiple
MutaTMMouse tissues following oral exposures to several
PAHs [Long et al., 2016]. In addition, we have employed
an in vitro version of the MutaTMMouse mutagenicity assay
to assess the mutagenic activity of complex PAH-containing
extracts from CT-contaminated soils [Lemieux et al.,
2015a,b]. Herein we report the genotoxicity observed in
mice as a result of daily exposure to an extract of CT-based
sealcoat, including the frequency of stable DNA adducts
and mutations found in bone marrow, liver, lung, small
intestine, and glandular stomach, as well as the frequency
of chromosome damage in peripheral red blood cells.
MATERIALS ANDMETHODS
Driveway Sealcoat Handling and Extraction
All chemicals used for the extraction were analytical grade and
obtained from EMD Chemicals (Gibbstown, NJ, USA). A 15-L pail of
CT-based sealcoat was purchased from a local home improvement retail-
er. The product is a water-based CT emulsion that, according to the
Material Safety Data Sheet for the product, contains 10–30% high-
temperature CT pitch (CAS # 65996-93-2) by weight. The sealcoat was
thoroughly homogenized and aliquots of the homogenized material were
dispensed on to several large glass petri dishes to air dry for 48 h. This
drying process resulted in a total dry weight of 25% of the bulk sealcoat
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(i.e., water content 75%). Approximately 10 g of dry sealcoat was
then scraped from the surface of the petri dishes, weighed on an analyti-
cal balance, and transferred to a coffee grinder, where it was ground
into a fine powder. The resulting powder was combined with 25 g of
attapulgus clay (Forcoven Products, Humble, TX), and extracted using a
method adapted from Wise et al. [1988] that permits removal of solvent-
insoluble hydrocarbons (e.g., asphaltenes) and isolation of the complex,
PAH-containing fraction for chemical and toxicological analyses. Brief-
ly, the sealcoat/clay mixtures were applied to three 10 cm diameter open
columns each packed with 300 g of attapulgus clay conditioned with
10% dichloromethane (DCM) in pentane prior to the extraction. The fol-
lowing amount of dried CT sealcoat was applied to each column: (a)
10.47 g, (b) 10.11 g, and (c) 10.05 g. The columns were eluted with
1.8 l of 10% DCM in pentane, and the eluate was combined into a sin-
gle vial and evaporated under ultrapure nitrogen until a viscous dark
brown liquid remained that could no longer be reduced. The final vol-
ume of the sealcoat eluate was 5.85 ml. A small aliquot (100 ml) was
removed for chemical analyses, and the remainder used to prepare dos-
ing solutions by first sonicating the eluate and then diluting the material
in an appropriate quantity of highly refined olive oil (Sigma-Aldrich
Canada, Oakville, ON). Doses were prepared based on the mg equiva-
lent (eq) weight of the crude (i.e., wet) sealcoat.
Chemical Analysis by GC^MS
The PAH content of the sealcoat concentrate was determined using
GC–MS according to US EPA Method 8270D. The analyses were con-
ducted by a commercial laboratory accredited by the Canadian Associa-
tion for Laboratory Accreditation (CALA), the National Institute of
Standards and Technology, and the National Voluntary Laboratory
Accreditation Program. Briefly, the samples were warmed and diluted
with DCM and an aliquot was analyzed on an Agilent 6890N gas chro-
matograph with a split/splittless injector and Restek Rxi-5Sil MS column
(30 mm 3 0.25 mm ID, film thickness 0.25 lm, Chromatographic Spe-
cialties, Brockville, ON). Target analytes were identified and quantified
using an Agilent 5973N mass spectrometer operating in SIM (selected
ion monitoring) mode. The concentrations of a standard panel of 19
PAHs were determined and results expressed as mg PAH/kg sealant-eq.
This includes the 16 priority PAHs, as well as seven PAHs designated
by the US EPA as class B2 carcinogens (i.e., probable human carcino-
gens) [USEPA, 1993].
Animal Treatment
Adult MutaTMMouse (strain 40.6) males (18-weeks of age) were ran-
domly assigned to a dose group and individually housed in microVENT
ventilated racks (Allentown, Allentown, NJ). The mice received standard
rodent chow (2014 Teklad Global standard rodent diet) and water ad
libitum for the duration of the study, and were maintained on a 12-h
light/12-h dark cycle. The dosing solution was administered at 0.005 ml/
g body weight (BW). The sealcoat extract was dissolved in highly
refined olive oil and prepared at the following doses: 1974, 3949,
7897 mg crude sealcoat eq/kg BW/day. There were five mice in each
dose group, including the control group (20 animals in total). The seal-
coat extract was administered via oral gavage daily for 28-days, fol-
lowed by a 3-day sampling time (i.e., no additional doses) prior to
necropsy, according to OECD test guideline # 488 [OECD, 2011]. Two
days after the final dose, blood was obtained from the facial vein for
micronucleus frequency determination. Animals were euthanized via car-
diac puncture under isofluorane gas anaesthesia, followed by cervical
dislocation and chest cavity opening. The glandular stomach and small
intestine were rinsed with phosphate-buffered saline (PBS) (Thermo-
Fisher, Waltham, MA) to remove partially digested food and flash frozen
along with liver and lung. The bone marrow was flushed from both
femurs with PBS, pelleted, and flash frozen. All tissues were stored at
2808C. Mice were bred, maintained, and treated in accordance with the
Canadian Council for Animal Care Guidelines and the protocols were
approved by the Health Canada Ottawa Animal Care Committee.
DNA Extraction
Murine tissues were prepared for genomic DNA extraction as
described in Long et al. [2016]. Briefly, prepared tissues were suspended
in freshly prepared ice-cold lysis buffer [1 mM Na2EDTA, 100 mM
NaCl, 20 mM Tris–HCl, pH 7.4, 1% SDS (w/v)] and incubated over-
night at 378C with gentle shaking. Genomic DNA was isolated from
lysed tissues using a phenol/chloroform extraction procedure described
previously [Douglas et al., 1994; Vijg and Douglas, 1996]. Isolated
DNA was dissolved in 100 ml TE buffer (10 mM Tris pH 7.6, 1 mM
EDTA) and stored at 48C until use.
Analysis of DNA Adducts by 32P-Postlabeling
The nuclease P1 enrichment version of the thin-layer chromatography
(TLC) 32P-postlabeling assay was used to determine DNA adduct forma-
tion in bone marrow, liver, lung, glandular stomach, and small intestine.
The procedure was performed as described previously [Wohak et al.,
2014; Krais et al., 2015]. As in prior studies [Kim et al., 2011; Siddens
et al., 2012; Longhin et al., 2013; Molina et al., 2013], total DNA
adduct levels were measured in the diagonal radioactive zone (DRZ)
area of the TLC plates and were considered representative of PAH–
DNA and other aromatic/hydrophobic adducts resistant to nuclease P1
digestion. The method provides a summary measure of a complex mix-
ture of adducts present in the postlabeling chromatograms. The results
were expressed as DNA adducts/108 nucleotides.
Analysis of lacZMutations by the PGal Positive Selection
Assay
The PGal (phenyl-b-D-galactoside) positive selection assay was used
for the determination of lacZ mutant frequency in DNA samples from
bone marrow, liver, lung, glandular stomach, and small intestine, as pre-
viously described [Gossen et al., 1992; Vijg and Douglas, 1996; Lambert
et al., 2005]. Mutant frequency was calculated as the ratio of mutant pla-
que forming units (i.e., pfu) to total pfu.
Analysis of Peripheral Blood Micronuclei by Flow
Cytometry
MicroFlow
VR
kits (Litron Laboratories, Rochester, NY) were used for
enumeration of micronucleated reticulocytes (RET) and normochromatic
erythrocytes (NCE). Briefly, approximately 60 ml of peripheral blood
was immediately combined with 350 ml of anticoagulant. Blood samples
were then fixed by transferring to ice-cold methanol and stored at
2808C. After 3–5 days, fixed blood samples were then centrifuged,
rinsed, and transferred to a long-term storage solution. Coded specimens
were shipped to Litron Laboratories (Rochester, NY) for analysis.
Micronuclei were scored in NCEs (i.e., MN-NCEs) and RETs (i.e., MN-
RETs) by flow cytometry using a 3-color labeling method described in
Torous et al. [2001] and Dertinger et al. [2004].
Statistical Analysis
The lacZ and MN dose–response data were analyzed in SAS v.9.1
(SAS Institute, Cary, NC) by Poisson regression and a Type 3 chi-
squared analysis. The data were fit to the model log(E(Yi)) 5 log
ti 1 bxi, where E(Yi) is the expected value for the ith observation, b is
the vector of regressions coefficients, xi is a vector of covariates for the
ith observation, and ti is the offset variable used to account for differ-
ences in observation count period (e.g., total pfu). The offset (e.g.,
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natural log of pfu) was given a constant coefficient of 1.0 for each
observation, and log-linear relationships between mutant count and test
article concentration were specified by a natural log link function. Post
hoc custom contrasts based on the asymptotic chi-square distribution of
the likelihood ratio statistic were conducted to compare each dose group
with the control. Should visual examination suggest the need to truncate
the top dose, data were re-fit without the top dose, and if this resulted in
an improved chi-squared value, then the truncated results were retained,
and this was used for potency determination (see below).
The potency of the responses for each significant tissue/endpoint
combination was determined using ordinary least-squares linear regres-
sion and expressed as the slope of the linear portion of the dose–
response function. Individual animal genotoxicity results are available
from the author upon request.
RESULTS
Analysis of Sealcoat and Sealcoat Extract
Chemical analysis of the CT-based sealcoat revealed
that there are 44.2 g (4.4% w/w) of the US EPA priority
PAHs per kg of sealcoat, including 8.66 g (0.87% w/w)
of US EPA class B2 PAHs (i.e., probable human carcino-
gens), and 1.91 g (0.19% w/w) of benzo(a)pyrene (BaP)
(Table I). Concentrations in the sealcoat extract are
expressed in terms of sealcoat equivalents (eqs), which
were calculated based on the amount of crude sealcoat
that was extracted and submitted for chemical analysis.
Additionally, we calculated the total amount of PAHs
present in a 15-L pail of CT-based sealcoat (i.e., the
format available for retail purchase). The results indicate
that a 15-L pail contains more than 750 g of priority
PAHs and 147 g of B2 carcinogenic PAHs, including
32 g of BaP (Table I).
DNA Adduct Frequency
Bulky DNA adduct frequency, determined using 32P-
postlabeling analyses, was employed to document tissue-
specific exposures to DNA-damaging agents in the admin-
istered sealcoat extract. The results revealed statistically
significant increases in DNA adduct frequency relative to
controls in all tissues examined (Fig. 1). Furthermore,
damage frequency increased in a dose-dependent manner,
with potency (i.e., magnitude of response increase per
unit dose increase) varying across the tissues examined.
Analyses of the dose–response relationships revealed the
most potent response (i.e., highest slope) for the liver
(maximum response up to 102-fold over control), fol-
lowed by the lung (maximum response up to 60-fold over
control), glandular stomach (maximum response up to 14-
fold over control), small intestine (maximum response up
to 8-fold over control), and finally the bone marrow
(maximum response up to 5-fold over control).
lacZMutant Frequency
The frequency of lacZ mutants was assessed in five tis-
sues. The results revealed a statistically significant
TABLE I.Concentrations of Polycyclic Aromatic Hydrocarbons (PAHs) in CT-Based Driveway Sealcoat Extract (Expressed Per
Unit Weight of Crude Sealcoat), as Well as the Total Amount of PAHs per 15-L pail (i.e., the Commercially Available Size)
Polycyclic aromatic hydrocarbons CAS # Sealcoat (mg PAH/kg sealcoat) Per 15-L pail (g)
Acenaphthenea 83-32-9 2,433 41.30
Acenaphthylenea 208-96-8 BDL N/A
Anthracenea 120-12-7 1,582 26.85
Benz[a]anthracenea,b 53-55-3 1,325 22.50
Benzo[a]pyrenea,b 50-32-8 1,906 32.35
Benzo[b]fluoranthenea,b 205-99-2 1,407 23.89
Benzo[g,h,i]perylenea 191-24-2 958 16.26
Benzo[k]fluoranthenea,b 207-08-9 784 13.30
Biphenyl 92-52-4 87 1.48
Chrysenea,b 218-01-9 2,409 40.89
Dibenz[a,h]anthracenea,b 53-70-3 151 2.56
Fluoranthenea 206-44-0 8,706 147.78
Fluorenea 86-73-7 1,867 31.69
Indeno[1,2,3-cd]pyrenea,b 193-39-5 682 11.58
1-Methylnaphthalene 90-12-0 201 3.42
2-Methylnaphthalene 91-57-6 351 5.96
Naphthalenea 91-20-3 725 12.32
Phenanthrenea 85-01-8 11,850 201.15
Pyrenea 129-00-0 6,820 115.76
Total 44,242 751.01
Total 16 US EPA priority pollutant PAHs 43,603 740.16
Total US EPA B2 carcinogenic PAHs 8,663 147.06
The chemical abstract service number (i.e., CAS #) for each PAH is provided.
aDesignated a US EPA priority pollutant.
bDesignates a US EPA B2 carcinogen; eq: equivalents; BDL: below detection limit.
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response for each tissue with dose-dependent increases in
mutant frequency relative to controls and variations in
potency across the tissues examined (Fig. 2). The most
potent response (i.e., highest slope) was observed in the
small intestine (maximum response up to 154-fold above
control), followed by the liver (maximum response up to
51-fold above control), glandular stomach (maximum
response up to17-fold above control), bone marrow (max-
imum response up to 14-fold above control), and finally
lung (maximum response up to 6-fold above control). The
fact that the highest responses were seen in the site-of-
contact and related tissues emphasizes the importance of
examining these tissues following an oral administration.
Micronucleus Frequency
The frequency of micronucleated red blood cells
was assessed as a measure of clastogenicity in hemato-
poietic tissue. Statistically significant increases in
micronucleated RETs and NCEs were observed relative
to controls, with a 2.3-fold greater potency in RETs
(i.e., a potency of 0.000082 in RETs versus 0.000036
in NCE) (Fig. 3). The results emphasize the impor-
tance of scoring RETs to examine the effects of recent
damage.
DISCUSSION
This study used a 28-day repeat-dose oral exposure of
transgenic MutaTMMouse to assess the multiorgan geno-
toxicity of a PAH-containing extract of a commercially
available CT-based driveway sealcoat. The results
obtained clearly indicate that oral exposure to the purified
extract induces both significant increases in DNA damage
(i.e., adducts) and mutations (i.e., lacZ) across several tis-
sues, as well as chromosome damage (i.e., MN) in
peripheral blood cells.
Chemical analysis of the CT-based sealcoat examined
here revealed that it contains over 4% PAHs by weight,
Fig. 1. Relative adduct labeling [DNA adducts per 108 nucleotides (nt)]
in tissues from MutaTMMouse orally exposed to CT-based driveway seal-
coat (seal). Total frequency of adducts was determined from the diagonal
radioactive zone (DRZ). A: Dose response–data and potency (i.e., the
slope of the linear portion of the dose–response function) is presented for
each tissue. Lv: liver, Lg: lung, GS: glandular stomach, SI: small intes-
tine, BM: bone marrow. * indicates where data were truncated during sta-
tistical analysis, therefore the mutagenic potency is a result of fewer than
4 dose groups. B: Restricted y-axis scale to better display dose-response
data for GS, SI, and BM. Inserts: Representative autoradiographic profiles
of DNA adducts in lungs from untreated mice or mice subchronically
exposed to CT-based driveway sealcoat (these profiles are representative
of adduct profiles obtained with DNA from other mouse tissues including
liver, glandular stomach, small intestine, and bone marrow) . Solvent con-
ditions for the separation of PAH-derived DNA adducts using thin-layer
chromatography were as follows: D1, 1.0M sodium phosphate, pH 6.0;
D3, 3.5M lithium-formate, 8.5M urea, pH 3.5; D4, 0.8M lithium chloride,
0.5M Tris, 8.5M urea. The origins (OR), at the bottom left corner, were
cut off before imaging.
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with approximately 0.9% US EPA B2 PAHs. In compari-
son with available information on other CT-based seal-
coats, the product examined in this study contained a
lower concentration of PAHs. For example, in a study by
Bryer et al. [2006], the sealcoat contained 23% PAHs by
weight, with 5% B2 PAHs. Bommarito et al. [2010]
reported that the CT-based sealcoat examined in their
study was approximately 8% PAHs by weight, and nearly
3% B2 PAHs. It is important to note that crude CT, CT
pitch and products derived from CT pitch contain com-
plex mixtures of PAHs, with their relative composition
concentration varying widely with source and type of
material (e.g., crude CT versus high-temperature pitch).
Additionally, sealcoats such as that examined here can
contain 10–35% CT by weight and the final PAH content
of the product will depend on the CT concentration in
each batch. Although the PAH content of CTs will vary
according to the type of material (i.e., crude or refined)
and its source, the material generally used for the produc-
tion of CT-based pavement sealants is a derivative of CT
pitch known as RT-12. Although one might expect some
consistency in the PAH content of CT-based sealcoat
products containing RT-12, the source of the crude CT
and the exact RT-12 concentration in each sealcoat batch
(i.e., 10-35% by weight) affects the final PAH content of
the sealcoat [USGS, 2011]. Moreover, the certificate of
analysis for the National Institute of Standards and Tech-
nology Standard Reference Material 1597 (i.e., a complex
mixture of PAHs from CT), which employed the Wise
et al. [1988] method also used here, notes the presence of
other polyaromatic compounds including sulphur hetero-
cyclics, along with PAHs. This is consistent with our ear-
lier work [Lundstedt et al., 2006; Lemieux et al., 2008]
that employed a similar approach to prepare PAH-
containing extracts from CT-contaminated soils, and not-
ed that extracts can contain N- and S-heterocyclics, in
addition to homocyclic PAHs, all of which may contrib-
ute to the overall genotoxicity of the mixture.
The most potent DNA adduct response was observed in
liver and lung, followed by glandular stomach. This pat-
tern of CT-induced DNA adducts across murine tissues
following oral exposure is similar to what was observed
in the CT study of Culp and Beland [1994]. More specifi-
cally Culp and Beland assessed bulky DNA adduct fre-
quency in several mouse tissues following dietary
administration of CT for 21 days, and noted that levels
were highest in lung, followed by liver and forestomach
[Culp and Beland, 1994]. The presence of stable DNA
adducts in a particular tissue indicates that the tissue was
exposed to DNA-reactive metabolites (e.g., PAH-diol-
Fig. 2. The lacZ mutant frequency in tissues from MutaTMMouse orally exposed to CT-based driveway sealcoat (seal).
A Dose–response data and potency (i.e., the slope of the linear portion of the dose–response function) is presented for
each tissue. SI: small intestine, Lv: liver, GS: glandular stomach, BM: bone marrow, Lg: lung. B Restricted y axis to
better display dose–response data for BM and Lg.
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epoxides). This can occur via CYP1-mediated metabolism
within the target tissue, and/or alternatively, metabolism
in the gastrointestinal system followed by systemic circu-
lation of reactive metabolites and tissue delivery. For
example, the reactive form of BaP (i.e., benzo(a)pyrene-
diol-epoxide; BPDE) has been identified in serum follow-
ing an oral exposure to BaP [Ginsberg and Atherholt,
1989]; however, due to the highly reactive nature of these
metabolites, it is more likely that the production of DNA-
reactive metabolites occurs in situ in each tissue. Indeed,
it has previously been demonstrated in several mouse
models that the tissues examined here have constitutive
or inducible levels of CYP1A1, 1A2, and/or 1B1, all of
which are known to convert PAHs to DNA-reactive
metabolites [Choudhary et al., 2003; Nebert et al., 2004;
Uno et al., 2008; Renaud et al., 2011; Nebert et al., 2013;
Arlt et al., 2015]. Moreover, our lab group has previously
demonstrated induction of CYP1A1 and 1B1 in Muta-
TMMouse lung and liver following an identical oral expo-
sure regime to several individual PAHs [Labib et al.,
2015].
The most potent response for induction of lacZ muta-
tions was observed in the small intestine, followed by liv-
er, glandular stomach, bone marrow, and lung. For an
oral exposure route, glandular stomach and small intestine
are both initial site-of-contact tissues, with liver being
closely related; whereas, both bone marrow and lung
require distribution of the sealcoat compounds and/or
compound metabolites via systemic and/or pulmonary cir-
culation. These results support the contention that the pro-
duction of DNA-reactive metabolites occurs in situ. It is
therefore not unexpected that the highest level of
response induction was observed for site-of-contact and
related tissues (i.e., stomach, liver, small intestine) prior
to complete metabolism, detoxification and excretion.
Nebert et al. [2013] demonstrated the importance of
metabolism in small intestine and liver in the initial
detoxification of orally-delivered BaP. Efficient detoxifi-
cation in the gastrointestinal system, and subsequent
excretion of conjugates via the bile, would reduce the
amount of compound and/or compound metabolite avail-
able for delivery to distal tissues. This contention is con-
sistent with the high levels of CYP1 isozymes that have
been observed in liver and small intestine (i.e., CYP1A2
in the liver, CYP1A1/1B1 in small intestine) [Uno et al.,
2008; Shi et al., 2010a,b]. These isozymes are capable of
converting PAHs into DNA-reactive metabolites, thus
contributing to elevated mutagenic responses in these
tissues.
Despite significant increases in genotoxic damage
across all endpoints and tissues, the results show clear
differences in the tissue-specific patterns of DNA adduct
and lacZ mutation induction. As noted, the most potent
adduct responses were observed in liver and lung; where-
as, for lacZ mutations, the most potent response was
observed for small intestine, with the least potent
response observed in lung. Although the precise cause of
this discrepancy remains to be determined, it seems rea-
sonable to assert it relates to tissue-specific differences in
repair capacity and cellular proliferation rate. Conversion
of DNA damage to permanent sequence changes (i.e.,
mutations) is controlled by a complex series of dynamic
processes that control damage processing and repair, and
cellular proliferation, and although a discussion of the
mechanistic nuances of the process is beyond the scope
of this work, it is interesting to note that cells in the lung
and liver have relatively low proliferation rates in com-
parison with the other tissues examined herein (unpub-
lished data). This would be expected to limit the
conversion of adducts to mutations; moreover, tissue-
specific differences in damage processing and repair can
be expected to augment or diminish the establishment of
mutations. Although most cells in liver and lung tissues
have low mitotic indices, lung has been shown to have an
elevated capacity for error-free lesion bypass that could
contribute to a reduction in the conversion of adducts to
mutations [Velasco-Miguel et al., 2003]. More specifi-
cally, Ogi et al. [2002] noted that expression of the trans-
lesion DNA polymerase Pol j is AhR-dependant (i.e.,
PAH-inducible), and Bi et al. [2005] noted that Pol j is
required for recovery from BPDE-induced cell cycle
checkpoint. Thus, although the precise causes of the
observed crosstissue patterns in induced DNA adduct and
mutation levels remain to be determined, dynamic differ-
ences in tissue specific metabolism, cellular growth, and
DNA damage and repair likely play key roles.
Exposure to the sealcoat extract induced a significant
increase in the frequency of micronucleated RETs and
NCEs, although the fold-increase in event frequency is
much lower in comparison with the lacZ mutation and
Fig. 3. The frequency of micronuclei in peripheral blood from Muta-
TMMouse orally exposed to CT-based driveway sealcoat (seal). Potency
(i.e., the slope of the linear portion of the dose-response function) is pre-
sented for each tissue. RET: reticulocytes, NCE: normochromatic erythro-
cytes. * indicates where data were truncated during statistical analysis,
therefore the mutagenic potency is a result of fewer than four dose
groups.
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DNA adduct endpoints. It is well recognized that the pri-
mary mode of action for genotoxic PAHs is induction of
mutations via formation and mis-repair of bulky adducts;
however, PAHs have also been previously shown to
induce clastogenic effects and elevated levels of chromo-
somal damage [Glatt et al., 1990; He and Baker, 1991;
Crofton Sleigh et al., 1993; Warshawsky et al., 1995;
Whong et al., 1994; Nishikawa et al., 2005; Schober
et al., 2006; Lemieux et al., 2011; Abramsson Zetterberg
et al., 2013]. The results obtained showed significant ele-
vations in micronuclei, which are thought to be produced
during cellular replication following DNA double strand
breaks [Fenech et al., 2011]. These results are consistent
with a previous study by our group that employed an
identical study design to evaluate the genotoxicity of
8 priority PAHs. The results of that study showed that 4
of the priority PAHs examined (i.e., BaP, dibenz(a,h)an-
thracene, benzo(b)fluoranthene, and benzo(k)fluoranthene)
induced significant increases in the frequency of micro-
nucleated red blood cells [Long et al., 2016].
The product instructions for the sealcoat examined in
this study indicates that a 15-L pail contains sufficient
material to cover an area of 20 to 49 m2, and additional-
ly, that it is a “1-year sealcoat” that should be reapplied
annually. Thus, for homeowners with a typical double-car
driveway (e.g., 36 m2) at least a full pail of sealcoat
would be required for annual pavement maintenance, and
therefore annual application of total priority PAHs for a
typical household would exceed 750 g, including 147 g
of US EPA B2 carcinogenic PAHs and 32 g of BaP.
Despite the level of PAHs in coal tar-based sealcoat, gen-
otoxic hazard, and the recommended application amount
and frequency, the risk of adverse human health effect
depends on the potential for exposure, as well as the
route, level, and duration of exposure. Clearly, the magni-
tude of human exposure to the product, and by extension
the PAHs in the product, will depend on the magnitude
and frequency of contact with the product (e.g., during
application), contact with the pavement surface, and con-
tact and/or oral ingestion of PAH-contaminated particu-
late material (e.g., pavement dust and house dust) from
weathered pavement. Although currently available infor-
mation does not permit accurate determination of total
human exposure to PAHs in the product or materials
derived from the product, studies such as that by Wil-
liams et al. [2013] estimated the level of exposure (in ng
BaP equivalents/kg BW/day) of individuals inhabiting
residences adjacent to surfaces treated with CT-based
sealcoats. Moreover, Williams et al. estimated the excess
lifetime cancer risk associated with nondietary ingestion
of PAH-contaminated soils and SHDs collected in close
proximity to CT-sealed pavements, and determined that
values can exceed 1 3 1024 [Williams et al., 2013], a
level that exceeds the essentially negligible cancer risk
for contaminated site risk assessment [Health Canada,
2012].
Published studies that investigated the murine carcino-
genicity of CT have examined crude high-temperature CT
rather than the aforementioned refined material that is
used in the production of CT-based sealcoat products
[Culp et al., 1998; Goldstein et al., 1998]. Nonetheless, it
is interesting to compare the results of the Culp et al.
[1998] and Goldstein et al. [1998] studies to those
obtained here. A 2-year rodent cancer bioassay involving
B6C3F1 mice fed CT-amended food found carcinomas in
liver, lung, forestomach, and small intestine, with the
highest tumour incidence observed in small intestine fol-
lowed by lung [Culp et al., 1998; Goldstein et al., 1998].
This tumour induction pattern corresponds with the results
of this study (i.e., highest levels of mutations and/or
adducts in lung, liver and intestine). Despite the facts that
not all mutagens are necessarily carcinogens and that the
current study examined an extract of a CT-containing
pavement sealcoat rather than crude CT, the cross-tissue,
multi-endpoint responses observed herein, and the corre-
spondence between genotoxicity herein and earlier carci-
nogenicity results, strongly suggest that oral exposure to
CT-based sealcoat products would also induce rodent car-
cinomas in multiple tissues in longer-term studies. This is
especially concerning, since numerous studies by Mahler,
van Metre, and colleagues [Metre et al., 2008; Mahler
et al., 2010; Van Metre et al., 2012; Williams et al.,
2013] have clearly demonstrated a potential for human
exposure to mutagenic carcinogens in environmental sam-
ples (e.g., air, SHD, soil) collected in the vicinity of
pavements treated with CT-based sealcoats.
CONCLUSION
CT-based sealcoat products contain high levels of pri-
ority PAHs, including several mutagenic carcinogens, and
previous work has demonstrated that environmental sam-
ples derived from sealed pavements (e.g., runoff water) or
collected in the vicinity of surfaces treated with CT-based
sealcoats are similarly contaminated with priority PAHs
and induce toxic/genotoxic effects in a range of organ-
isms. Moreover, earlier work has documented the poten-
tial for human exposure via contact with PAH-
contaminated environmental matrices such as soil and
SHD collected near surfaces treated with CT-based seal-
coats. The results obtained in this study clearly demon-
strate that CT-based pavement sealcoat extract has the
ability to induce significant increases in genetic damage,
including DNA adducts, mutations and chromosomal
damage, in several tissues of orally exposed mice.
Although it is not possible to quantitatively translate the
magnitude of the observed rodent responses into effects
that may occur in humans, the work provides conclusive
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identification of in vivo mammalian genotoxic hazard
from oral exposure to a PAH extract from coal tar-based
driveway sealcoat.
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